Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 103, Issue 21, Pages 8173-8178Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0510254103
Keywords
cadherin; Rho; G protein-coupled receptor
Categories
Funding
- NCI NIH HHS [R01 CA063071, CA92240, R01 CA100869, R01 CA092240, 5P50 CA68438, CA063071, P50 CA068438, CA100869] Funding Source: Medline
- NIA NIH HHS [R01 AG017952, AG17952] Funding Source: Medline
- NIDDK NIH HHS [R01 DK060917, DK 60917, K08 DK062833, DK62833] Funding Source: Medline
Ask authors/readers for more resources
Although the prognosis for patients with early-stage breast cancer has improved, the therapeutic options for patients with locally advanced and metastatic disease are limited. To improve the treatment of these patients, the molecular mechanisms underlying breast cancer invasion and metastasis must be understood. In this study, we report that signaling through the G12 family of heterotrimeric G proteins (G alpha 12 and G alpha 13) promotes breast cancer cell invasion. Moreover, we demonstrate that inhibition of G12 signaling reduces the metastatic dissemination of breast cancer cells in vivo. Finally, we demonstrate that the expression of Ga12 is significantly up-regulated in the earliest stages of breast cancer, implying that amplification of G12 signaling may be an early event in breast cancer progression. Taken together, these observations identify the G12 family proteins as important regulators of breast cancer invasion and suggest that these proteins may be targeted to limit invasion- and metastasis-induced patient morbidity and mortality.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available